Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Immutep announces publication of ESMO 2023 abstracts (ASX:IMM)

New updated data from TACTI-002, including more mature Overall Survival data, will be presented during the Mini Oral session on Saturday, October 21st, at 9:05 CEST Immute...read more

Immutep announces acceptance of abstract for SITC 2023 (ASX:IMM)

SYDNEY, AUSTRALIA – 3 October 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing...read more

icetana - Security Purchase Plan (ASX:ICE)

For more information, download the attached PDF.

Immutep - Commercial Scale Manufacturing of Efti for Clinical Trials (ASX:IMM)

SYDNEY, AUSTRALIA – September 21, 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company develop...read more

INOVIQ - ASX Small and Mid-Cap Conference Investor Presentation (ASX:IIQ)

To view the presentation, download the attached PDF.

icetana - Share placement and SPP (ASX:ICE)

Highlights: icetana has agreed a private placement of $1,994,000 to strategic investors. The placement consists mainly of icetana’s three largest shareholders: tech entrepreneur ...read more

icetana - New hardware order $1.5m (ASX:ICE)

Highlights: icetana has received a new purchase order from its largest customer, a Middle East shopping mall conglomerate. The customer is purchasing GPU-intensive servers to run iceta...read more

icetana - Trading Halt (ASX:ICE)

For more information, download the attached PDF.

Immutep - 2023 AGM & Key Dates (ASX:IMM)

SYDNEY, AUSTRALIA – 8 September 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) advises that in accordance with ASX Listing Rule 3.13.1, that it intends to hold its 2023 Annual General M...read more

Immutep to Participate in September Investor Conferences (ASX:IMM)

SYDNEY, AUSTRALIA – 6 September 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical stage biotechnology company developing nov...read more

INOVIQ and ResearchDx sign USA EXO-NET Services Agreement (ASX:IIQ)

INOVIQ and ResearchDx sign a license and supply agreement for INOVIQ’s EXO-NET® pan-exosome capture product to provide EXO-NET services in the USA ResearchDx Inc is a...read more

icetana - Full Year Statutory Accounts (ASX:ICE)

To view the Full Year Statutory Accounts, download the attached PDF.

Immutep - Appendix 4E & 2023 Full Year Statutory Accounts (ASX:IMM)

To view the Appendix 4E & 2023 Full Year Statutory Accounts, download the attached PDF.

INOVIQ - Appendix 4E and Preliminary Financial Report (ASX:IIQ)

To view the Appendix 4E and Preliminary Financial Report, download the attached PDF.

icetana secures contract with Sydney Opera House (ASX:ICE)

Highlights: icetana has received a new order for its AI software solution from Australian landmark Sydney Opera House. The latest icetana version was selected during a competitive...read more

Viewing: 106 - 120 of 200 Previous | Next